Skip to main content
Log In
Sign Up
Home
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Watchlist
Collapse
Home
»
Analysts
»
Eddie Hickman
Eddie Hickman
Stock Analyst at Guggenheim
(2.95)
# 1,569
Out of 4,732 analysts
7
Total ratings
71.43%
Success rate
30.32%
Average return
Main Sectors:
Healthcare
Top Industries:
Biotechnology
Stocks Rated by Eddie Hickman
Stock
Action
Price Target
Current
Upside
Ratings
Updated
OTLK
Outlook Therapeutics
Reiterates:
Buy
$12
$2.23
+438.12%
3
Jan 17, 2025
TARS
Tarsus Pharmaceuticals
Maintains:
Buy
$46
→
$49
$46.52
+5.33%
4
Sep 11, 2023
OTLK
Outlook Therapeutics
Jan 17, 2025
Reiterates:
Buy
Price Target:
$12
Current: $2.23
Upside:
+438.12%
3 Ratings
View All
TARS
Tarsus Pharmaceuticals
Sep 11, 2023
Maintains:
Buy
Price Target:
$46
→
$49
Current: $46.52
Upside:
+5.33%
4 Ratings
View All